The comparative effects of n-3 and n-6 polyunsaturated fatty acids on plasma fibrinogen levels: a controlled clinical trial in hypertriglyceridemic subjects.

It has previously been shown that fish oil supplementation, compared to olive oil, reduces plasma fibrinogen. Presented here are the results of a randomized, double-blind, crossover controlled trail that compared the effects of dietary n-3 and n-6 fatty acid supplementation on plasma fibrinogen levels in 10 patients with hyperlipoproteinemia types IIb or IV. Plasma fibrinogen levels showed statistically significant reductions during both the fish oil and corn oil treatment periods. Other variables related to hemostasis which showed no significant changes from baseline included tissue plasminogen activator activity and inhibitor, protein C antigen, antithrombin III activity, bleeding time, and platelet counts. These data confirm the two previous reports that fish oil supplementation is associated with reductions in plasma fibrinogen levels, thereby modifying a potential nonlipid risk factor for cardiovascular disease. Unlike previous reports, however, n-6 polyunsaturated fatty acids were also associated with significant reductions in fibrinogen levels. Therefore, it is premature to conclude that the fibrinogen-lowering effects of dietary fish oil are unique to n-3 polyunsaturated fatty acids.

[1]  J. Hansen,et al.  Effects of dietary supplementation with cod liver oil on monocyte thromboplastin synthesis, coagulation and fibrinolysis , 1989, Journal of internal medicine. Supplement.

[2]  E. Schmidt,et al.  n‐3 fatty acids and leucocytes , 1989, Journal of internal medicine. Supplement.

[3]  G. Huster,et al.  Dietary supplementation with low-dose fish oils lowers fibrinogen levels: a randomized, double-blind controlled study. , 1989, Annals of internal medicine.

[4]  K. Radack,et al.  Effects of modest doses of omega-3 fatty acids on lipids and lipoproteins in hypertriglyceridemic subjects. A randomized controlled trial. , 1989, Archives of internal medicine.

[5]  R. Mesa-Tejada,et al.  Identification and Distribution of Fibrinogen, Fibrin, and Fibrin(ogen) Products in Atherosclerosis: Use of Monoclonal Antibodies , 1989, Arteriosclerosis.

[6]  A. Bini.  Identification and distribution of fibrinogen, fibrin and fibrin (ogen) degradation products in atherosclerosis , 1989 .

[7]  S. Kristensen,et al.  Antithrombin III and protein C in stable angina pectoris--influence of dietary supplementation with polyunsaturated fatty acids. , 1988, Scandinavian journal of clinical and laboratory investigation.

[8]  T. Bjerkedal,et al.  Fish oil and plasma fibrinogen. , 1988, BMJ.

[9]  G. Hornstra.  Effect of Dietary Lipids on Arterial Thrombus Formation: Rationale for the Support of Drug Therapy by Diet , 1988, Seminars in thrombosis and hemostasis.

[10]  S. Kristensen,et al.  The effect of fish oil on lipids, coagulation and fibrinolysis in patients with angina pectoris. , 1988, Artery.

[11]  K. Austen,et al.  The effects of N-3 polyunsaturated fatty acids on the generation of platelet-activating factor-acether by human monocytes. , 1987, Journal of immunology.

[12]  T. Meade,et al.  EFFECTS OF CHANGES IN SMOKING AND OTHER CHARACTERISTICS ON CLOTTING FACTORS AND THE RISK OF ISCHAEMIC HEART DISEASE , 1987, The Lancet.

[13]  R. D'Agostino,et al.  Fibrinogen and risk of cardiovascular disease. The Framingham Study. , 1987, JAMA.

[14]  L Wilhelmsen,et al.  Analysis of risk factors for stroke in a cohort of men born in 1913. , 1987, The New England journal of medicine.

[15]  B. Butland,et al.  Effects of a fish oil supplement on serum lipids, blood pressure, bleeding time, haemostatic and rheological variables. A double blind randomised controlled trial in healthy volunteers. , 1987, Atherosclerosis.

[16]  J. Hall,et al.  Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpura. , 1986, The Journal of laboratory and clinical medicine.

[17]  T. Sanders,et al.  Effects of a fish oil supplement on platelet function, haemostatic variables and albuminuria in insulin-dependent diabetics. , 1986, Thrombosis research.

[18]  S. Thompson,et al.  HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY , 1986, The Lancet.

[19]  T. Kjellström,et al.  The fibrinolytic system and coagulation during bezafibrate treatment of hypertriglyceridemia. , 1986, Atherosclerosis.

[20]  V. Pollak,et al.  Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus. , 1984, The Journal of laboratory and clinical medicine.

[21]  L. Wilhelmsen,et al.  Fibrinogen as a risk factor for stroke and myocardial infarction. , 1984, The New England journal of medicine.

[22]  E. Schmidt,et al.  The Effect of N-6 and N-3 Polyunsaturated Fatty Acids on Hemostasis, Blood Lipids and Blood Pressure , 1983, Thrombosis and Haemostasis.

[23]  D. Comings.  Metabolic basis of inherited disease , 1983 .

[24]  T. Meade,et al.  HYPERTRIGLYCERIDAEMIA AND HYPERCOAGULABILITY , 1983, The Lancet.

[25]  N. Hogg.  Human monocytes are associated with the formation of fibrin , 1983, The Journal of experimental medicine.

[26]  K. Tanaka,et al.  Effects of fibrin and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in culture. , 1982, Atherosclerosis.

[27]  T. Meade,et al.  Effect of treatment of hyperlipidaemia on haemostatic variables. , 1980, British medical journal.

[28]  C. Forbes,et al.  Increased Plasma Fibrinogen and Platelet-Aggregates in Type II Hyperlipoproteinaemia , 1979, Thrombosis and Haemostasis.

[29]  M. Hills,et al.  The two-period cross-over clinical trial. , 1979, British journal of clinical pharmacology.

[30]  C. Kluft.  Studies on the Fibrinolytic System in Human Plasma: Quantitative Determination of Plasminogen Activators and Proactivators , 1979, Thrombosis and Haemostasis.

[31]  O. Odegård,et al.  Antithrombin (heparin cofactor) assay with "new" chromogenic substrates (S-2238 and Chromozym TH). , 1977, Thrombosis research.

[32]  L. Sherman,et al.  Specific binding of soluble fibrin to macrophages , 1977, The Journal of experimental medicine.

[33]  H. Dvorak,et al.  Fibrinogen/fibrin on the surface of macrophages: detection, distribution, binding requirements, and possible role in macrophage adherence phenomena , 1975, The Journal of experimental medicine.

[34]  J. Mackeith.  DISCHARGE OF VIOLENT PATIENTS , 1975, The Lancet.

[35]  Oxon Dm.  Obituary. Rupert Samuel Bruce Pearson. , 1974 .

[36]  E. W. Errill.  Rheology of blood. , 1969, Physiological reviews.

[37]  C. Laurell,et al.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. , 1966, Analytical biochemistry.

[38]  M. Verstraete,et al.  A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT test). , 1963, Clinica chimica acta; international journal of clinical chemistry.